OTC:GCAN
Greater Cannabis Company, Inc.
A struggling OTC holding company with zero reported revenue and substantial cash burn in the recent fiscal year.
Key Metrics
Investment Thesis
Bull Case
Investors might purchase GCAN as a speculative bet on a turnaround story, hoping for a sudden acquisition by a larger public cannabis firm or a breakthrough in regulatory approval that unlocks dormant assets. The low market capitalization offers high leverage potential if the company can successfully pivot to revenue generation within the next 12 months.
Bear Case
The stock should be avoided due to a confirmed insolvency risk where current liabilities dwarf current assets and cash reserves are rapidly depleting. There is no evidence of a viable path to profitability given five years of zero revenue and consistent losses, making the investment akin to buying lottery tickets with diminishing odds.
About Greater Cannabis Company, Inc.
Greater Cannabis Company (GCAN) operates as a holding company focused on the cannabis sector, currently reporting minimal revenue and significant accumulated losses. The firm navigates a highly regulated industry with limited current operational scale, relying heavily on capital markets for liquidity. Its financial profile reflects a pre-revenue or early-stage development phase within the broader North American cannabis market.
Analysis
Management Discussion
Management has failed to generate any positive operating profit or revenue over the last three years, with net losses widening from -$0.4M in 2022 to sustained deficits in 2023 and 2024. The balance sheet is critically fragile, showing a net cash burn of $109k while maintaining only $57k in ending cash against $898k in liabilities. Operating expenses of $156k far exceed the company's ability to fund its current trajectory without immediate external financing.
Industry Overview
The global cannabis industry is poised for significant growth as legalization spreads, yet it remains capital intensive with high barriers to entry regarding regulatory compliance. Many smaller OTC companies struggle to secure funding and scale operations effectively against larger, publicly traded competitors with better access to debt and equity markets. GCAN operates in this volatile environment without the financial buffer required to survive prolonged periods of low or zero revenue.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Expenses | $177.0K | $175.4K | $156.3K |
| Operating Income | $-177.0K | $-175.4K | $-156.3K |
| Amortization | — | — | $5.0K |
| Non-Operating Income | $-183.2K | $-13.0K | $-22.8K |
| Pre-Tax Income | $-360.3K | $-188.4K | $-179.0K |
| Income Tax | $0 | $0 | $0 |
| Continuing Ops | $-360.3K | $-188.4K | $-179.0K |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-360.3K | $-188.4K | $-179.0K |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-360.3K | $-188.4K | $-179.0K |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Current Assets | $270.0K | $166.9K | $57.4K |
| Cash & Equivalents | $270.0K | $166.9K | — |
| Other Current Assets | $0 | $0 | — |
| Long-Term Assets | $10.4K | $5.4K | $417 |
| Total Assets | $280.4K | $172.3K | $57.8K |
| Current Liabilities | $825.3K | $833.5K | $898.1K |
| Accounts Payable | $16.3K | $6.1K | $7.9K |
| Other Current Liab | $809.0K | $827.4K | $890.2K |
| Long-Term Liabilities | $0 | $0 | $0 |
| Total Liabilities | $825.3K | $833.5K | $898.1K |
| Shareholders' Equity | $-544.8K | $-661.2K | $-840.3K |
| Paid-In Capital | $3.0M | $3.0M | $3.0M |
| Retained Earnings | $-4.3M | $-4.5M | $-4.7M |
| Total L&E | $280.4K | $172.3K | $57.8K |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-360.3K | $-188.4K | $-179.0K |
| Non-Cash Adjustments | $163.8K | $5.0K | $5.0K |
| Working Capital Changes | $88.9K | $80.2K | $64.5K |
| Cash from Operations | $-107.5K | $-103.2K | $-109.5K |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-107.5K | $-103.2K | $-109.5K |
| Beginning Cash | $377.5K | $270.0K | $166.9K |
| Ending Cash | $270.0K | $166.9K | $57.4K |
Frequently Asked Questions
How does Greater Cannabis Company, Inc. make money?
The company currently reports no active revenue-generating segments, resulting in zero cost of revenue and gross profit. All financial activity is characterized by negative net income and a lack of diversified income streams typical of established cannabis operators.
What are the main risks for GCAN?
Severe liquidity crisis indicated by negative cash flow from operations exceeding $109k and a current liability position nearly 16x higher than current assets. The company faces an existential threat from its accumulated retained earnings deficit of $4.7M and total liabilities surpassing $898k. Absence of revenue growth for five consecutive years signals potential business model failure or inability to scale operations.
What is GCAN's competitive advantage?
Potential access to specialized regulatory knowledge within specific jurisdictions, a lean corporate structure minimizing overhead despite losses, and the theoretical optionality of future asset acquisitions or partnership ventures.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.